Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Single-Use Device Reuse Needs Greater Federal Oversight - FDA, GAO

This article was originally published in The Gray Sheet

Executive Summary

Manufacturers' inclusion of instructions for devices labeled for single-use on how to clean and reprocess the products would constitute a deceptive practice in the eyes of FDA, Center for Devices and Radiological Health Director David Feigal testified June 27.

You may also be interested in...



AMDR, Consumer Group Clash Over Reprocessed SUD Risk

The Center for Patient Advocacy's recent attempts to focus public attention on the safety risks of reprocessed single-use devices (SUDs) have drawn criticism from the Association of Medical Device Reprocessors

AMDR, Consumer Group Clash Over Reprocessed SUD Risk

The Center for Patient Advocacy's recent attempts to focus public attention on the safety risks of reprocessed single-use devices (SUDs) have drawn criticism from the Association of Medical Device Reprocessors

Class I Device Reprocessing Costs Prohibitive For Most Hospitals, AHA Claims

Third-party reprocessors may lack the capacity to fulfill the demands of hospitals unable to comply with FDA's regulatory requirements for single-use devices (SUDs), scheduled to take effect Aug. 14.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013579

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel